NCT04059484 2026-02-24
AMEERA-3
Sanofi
Phase 2 Terminated
Clinical Trials
6 trialsNCT04659603 2025-10-01
CARMEN-BT01
Sanofi
Phase 2 Terminated
NCT05420779 2024-05-08
A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations
Tasly Pharmaceutical Group Co., Ltd
Phase 2 Recruiting
NCT04262804 2023-08-22
A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC
Zai Lab (Hong Kong), Ltd.
Phase 2 Unknown
NCT04556292 2020-09-21
A Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer Patients
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Phase 2 Unknown
NCT02664103 2018-02-01
METRO-ABC
Sanofi
Phase 2 Completed